首页> 外文期刊>Drug and alcohol dependence >Dual mental health diagnoses predict the receipt of medication-assisted opioid treatment: Associations moderated by state Medicaid expansion status, race/ethnicity and gender, and year
【24h】

Dual mental health diagnoses predict the receipt of medication-assisted opioid treatment: Associations moderated by state Medicaid expansion status, race/ethnicity and gender, and year

机译:双心理健康诊断预测药物辅助阿片治疗的收到:由国家医疗补助扩张地位,种族/民族和性别和年度受到主持的协会

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Mental health diagnoses (MHD) are common among those with opioid use disorders (OUD). Methadone/buprenorphine are effective medication-assisted treatment (MAT) strategies; however, treatment receipt is low among those with dual MHDs. Medicaid expansions have broadly increased access to OUD and mental health services over time, but MAT uptake may vary depending on multiple factors, including MHD status, state Medicaid expansion decisions, and race/ethnicity and gender. Examining clinical and policy approaches to promoting MAT uptake may improve services among marginalized groups.
机译:背景:心理健康诊断(MHD)在阿片类药物使用障碍(OUD)中是常见的。 美沙酮/丁丙诺啡是有效的药物辅助治疗(MAT)策略; 然而,治疗收据在具有双MHD的人中低。 Medicaid扩展随着时间的推移,扩大了对Oud和心理健康服务的访问,但垫子摄取可能因多个因素而异,包括MHD状态,国家医疗补助扩展决策和种族/种族和性别。 检查促进垫子摄取的临床和政策方法可以改善边缘化群体之间的服务。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号